Consultant
Current- Consulted on projects across all stages of asset development (preclinical to marketed), involving different types of treatments, including standards of care, gene therapies, and biosimilars- Worked on projects across different indications, including acute myeloid leukemia, myelodysplastic syndrome, cervical cancer, asthma, atopic dermatitis, inflammatory bowel disease, ulcerative colitis, and Duchenne muscular dystrophy- Built competitor landscapes, performed treatment paradigm analyses, crafted competitive threat assessments, and generated implications for client considerations- Synthesized industry themes from market trends, pivotal data readouts, and health care providers’ perceptions- Generated several different types of deliverables, including alerts, monthly and quarterly presentations, approval timeline assumptions, data comparisons, playbooks, as well as pre, peri and post conference outputs based on research and internal recommendations- Monitored news flow, investor relation events, press releases, medical journals and trial databases for clinical, regulatory or commercial updates; collaborated with project team members to analyze findings and develop conclusions- Identified gaps in patient journeys; provided clients with potential clinical impact opportunities and developed tactics to address them - Lead client meetings, researched ad-hoc client requests, and communicated with clients daily- Delegated tasks across projects, reviewed analyst outputs, and provided detailed feedback as needed- Lead project specific trainings for both clients and project teammates- Created guidance documents and templates for project deliverables- Attended conferences to gather perspectives from key opinion leaders